All Stories

  1. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines

    Article • Nature Communications, May 2019, Springer Science + Business Media

    Professor Albert Pares

  2. EASL Clinical Practice Guidelines on nutrition in chronic liver disease

    Article • Journal of Hepatology, January 2019, Elsevier

    Professor Albert Pares

  3. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival

    Article • Gastroenterology, January 2019, Elsevier

    Professor Albert Pares

  4. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French–Spanish experience

    Article • Clinics and Research in Hepatology and Gastroenterology, December 2018, Elsevier

    Professor Albert Pares

  5. Colangitis biliar primaria

    Article • Medicina Clínica, September 2018, Elsevier

    Professor Albert Pares

  6. Primary biliary cholangitis and bone disease

    Article • Best Practice & Research Clinical Gastroenterology, June 2018, Elsevier

    Professor Albert Pares

  7. Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

    Article • Hepatology, April 2018, Wiley

    Xavier Verhelst, Professor Albert Pares

  8. Osteoporosis in chronic liver disease

    Article • Liver International, March 2018, Wiley

    Professor Albert Pares

  9. A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis

    Article • Hepatology, January 2018, Wiley

    Roger Chapman, Professor Albert Pares

  10. Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment

    Article • Revista Española de Enfermedades Digestivas, January 2018, Sociedad Espanola de Patologia Digestiva (SEPD)

    Professor Albert Pares

  11. Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome

    Article • The American Journal of Gastroenterology, December 2017, Wolters Kluwer Health

    Professor Albert Pares

  12. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis

    Article • Clinical Gastroenterology and Hepatology, December 2017, Elsevier

    Professor Albert Pares

  13. Advances in treatment options for patients with primary biliary cholangitis

    Article • Expert Opinion on Orphan Drugs, October 2017, Taylor & Francis

    Professor Albert Pares

  14. Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response

    Article • The American Journal of Gastroenterology, October 2017, Wolters Kluwer Health

    Professor Albert Pares

  15. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis

    Article • Gut, August 2017, BMJ

    Professor Albert Pares, Prof. Dr. Bart van Hoek

  16. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Article • Gastroenterology, June 2017, Elsevier

    Professor Albert Pares

  17. Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial

    Article • Trials, May 2017, Springer Science + Business Media

    Professor Albert Pares, Prof. Dr. Bart van Hoek

  18. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study

    Article • Liver International, April 2017, Wiley

    Professor Albert Pares

  19. Juan Rodés. A successful and extraordinary life of a visionary hepatologist

    Article • Gut, March 2017, BMJ

    Professor Albert Pares

  20. An appealing new agent for treating cholestatic pruritus

    Article • The Lancet, March 2017, Elsevier

    Professor Albert Pares

  21. Novel Treatment Strategies for Primary Biliary Cholangitis

    Article • Seminars in Liver Disease, February 2017, Thieme Publishing Group

    Professor Albert Pares

  22. Expert clinical management of autoimmune hepatitis in the real world

    Article • Alimentary Pharmacology & Therapeutics, December 2016, Wiley

    Professor Albert Pares, Prof. Dr. Bart van Hoek

  23. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    Article • Nature Genetics, December 2016, Nature

    Professor Albert Pares

  24. Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers

    Article • The American Journal of Gastroenterology, October 2016, Nature

    Professor Albert Pares

  25. Colangitis biliar primaria

    Article • Medicine - Programa de Formación Médica Continuada Acreditado, May 2016, Elsevier

    Professor Albert Pares

  26. Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis

    Article • Journal of Bone and Mineral Research, April 2016, Wiley

    Professor Albert Pares

  27. Enteroendocrine cells are a potential source of serum autotaxin in men

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, April 2016, Elsevier

    Professor Albert Pares

  28. Preface

    Article • Digestive Diseases, December 2015, Karger Publishers

    Professor Albert Pares

  29. Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid

    Article • Digestive Diseases, December 2015, Karger Publishers

    Professor Albert Pares

  30. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    Article • Gastroenterology, December 2015, Elsevier

    Professor Albert Pares

  31. Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists

    Article • Hepatology, November 2015, Wiley

    Professor Albert Pares

  32. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’

    Article • Journal of Hepatology, November 2015, Elsevier

    Professor Albert Pares

  33. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’

    Article • Clinical Gastroenterology and Hepatology, November 2015, Elsevier

    Professor Albert Pares

  34. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’

    Article • Gastroenterology, November 2015, Elsevier

    Professor Albert Pares

  35. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’

    Article • Digestive and Liver Disease, November 2015, Elsevier

    Professor Albert Pares

  36. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’

    Article • Clinics and Research in Hepatology and Gastroenterology, October 2015, Elsevier

    Professor Albert Pares

  37. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’

    Article • The American Journal of Gastroenterology, September 2015, Nature

    Professor Albert Pares

  38. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’

    Article • Hepatology, September 2015, Wiley

    Professor Albert Pares

  39. Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

    Article • Gut, September 2015, BMJ

    Professor Albert Pares

  40. Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1

    Article • Hepatology, July 2015, Wiley

    Professor Albert Pares

  41. Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis

    Article • Hepatology, April 2015, Wiley

    Professor Albert Pares

  42. Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid

    Article • Gastroenterology, April 2015, Elsevier

    Professor Albert Pares

  43. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study

    Article • Gut, January 2015, BMJ

    Professor Albert Pares

  44. Bone Disease in Patients with Cirrhosis

    Article • January 2015, Springer Science + Business Media

    Professor Albert Pares

  45. TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency

    Article • Laboratory Investigation, December 2014, Nature

    Professor Albert Pares

  46. Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

    Article • Gastroenterology, December 2014, Elsevier

    Professor Albert Pares

  47. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis

    Article • European Journal of Clinical Investigation, November 2014, Wiley

    Professor Albert Pares

  48. Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers

    Article • Clinical Reviews in Allergy & Immunology, September 2014, Springer Science + Business Media

    Professor Albert Pares

  49. Old and Novel Therapies for Primary Biliary Cirrhosis

    Article • Seminars in Liver Disease, July 2014, Thieme Publishing Group

    Professor Albert Pares

  50. Treatment of primary biliary cirrhosis: Is there more to offer than ursodeoxycholic acid?

    Article • Clinical Liver Disease, February 2014, Wolters Kluwer Health

    Professor Albert Pares

  51. Extracorporeal liver support in severe alcoholic hepatitis

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Albert Pares

  52. Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis

    Article • Hepatology, October 2013, Wolters Kluwer Health

    Professor Albert Pares

  53. Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid

    Article • Liver International, September 2013, Wiley

    Professor Albert Pares

  54. Ursodeoxycholic acid protects osteoblastic cells from bilirubin and lithocholic acid induced apoptosis

    Article • May 2013

    Professor Albert Pares

  55. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Article • Nature Genetics, April 2013, Springer Science + Business Media

    Professor Albert Pares, Dr Tobias J. Weismüller

  56. Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells

    Article • Liver International, April 2013, Wiley

    Professor Albert Pares

  57. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial

    Article • Hepatology, March 2013, Wolters Kluwer Health

    Professor Albert Pares

  58. Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease

    Article • World Journal of Gastroenterology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Albert Pares

  59. Osteoporosis en la cirrosis hepática

    Article • Gastroenterología y Hepatología, June 2012, Elsevier

    Professor Albert Pares

  60. Sex Differences Associated with Primary Biliary Cirrhosis

    Article • Clinical and Developmental Immunology, January 2012, Hindawi Publishing Corporation

    Professor Albert Pares, Professor DIMITRIOS P BOGDANOS

  61. Tuberculosis Is Not a Risk Factor for Primary Biliary Cirrhosis: A Review of the Literature

    Article • Tuberculosis Research and Treatment, January 2012, Hindawi Publishing Corporation

    Professor Albert Pares

  62. Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?

    Article • World Journal of Gastroenterology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Albert Pares, Professor DIMITRIOS P BOGDANOS

  63. Effects of bilirubin and sera from jaundiced patients on osteoblasts: Contribution to the development of osteoporosis in liver diseases

    Article • Hepatology, December 2011, Wolters Kluwer Health

    Professor Albert Pares

  64. Hepatitis aguda alcohólica

    Article • Revista Española de Enfermedades Digestivas, November 2011, Instituto de Salud Carlos III/BNCS/SciELO Espana

    Professor Albert Pares

  65. Fibratos en el tratamiento de la cirrosis biliar primaria

    Article • Gastroenterología y Hepatología Continuada, November 2011, Elsevier

    Professor Albert Pares

  66. Colangiopatía IgG4. Características clínicas y diagnóstico diferencial

    Article • Gastroenterología y Hepatología Continuada, September 2011, Elsevier

    Professor Albert Pares

  67. Patients with cirrhosis and ascites have false values of bone density

    Article • Osteoporosis International, August 2011, Springer Science + Business Media

    Professor Albert Pares

  68. Proteomic Analysis of Polypeptides Captured from Blood during Extracorporeal Albumin Dialysis in Patients with Cholestasis and Resistant Pruritus

    Article • PLoS ONE, July 2011, PLOS

    Professor Albert Pares

  69. Management of osteoporosis in liver disease

    Article • Clinics and Research in Hepatology and Gastroenterology, June 2011, Elsevier

    Professor Albert Pares

  70. Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento

    Article • Gastroenterología y Hepatología, January 2011, Elsevier

    Professor Albert Pares

  71. Enfermedad de Caroli

    Article • Gastroenterología y Hepatología Continuada, January 2011, Elsevier

    Professor Albert Pares

  72. Print and Media Review

    Article • Gastroenterology, December 2010, Elsevier

    Professor Albert Pares

  73. Reply:

    Article • Hepatology, November 2010, Wolters Kluwer Health

    Professor Albert Pares

  74. Liver and bone

    Article • Archives of Biochemistry and Biophysics, November 2010, Elsevier

    Professor Albert Pares

  75. Characterization of peptides and proteins in commercial HSA solutions

    Article • PROTEOMICS - CLINICAL APPLICATIONS, September 2010, Wiley

    Professor Albert Pares

  76. Treatment of resistant pruritus from cholestasis with albumin dialysis: Combined analysis of patients from three centers

    Article • Journal of Hepatology, August 2010, Elsevier

    Professor Albert Pares

  77. Low Bone Mass and Severity of Cholestasis Affect Fracture Risk in Patients With Primary Biliary Cirrhosis

    Article • Gastroenterology, June 2010, Elsevier

    Professor Albert Pares

  78. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts

    Article • Endocrine, January 2010, Springer Science + Business Media

    Professor Albert Pares

  79. Lithocholic acid downregulates vitamin D effects in human osteoblasts

    Article • European Journal of Clinical Investigation, January 2010, Wiley

    Professor Albert Pares

  80. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts

    Article • Endocrine, November 2009, Springer Science + Business Media

    Professor Albert Pares

  81. Characterization of peptides and proteins in commercial HSA solutions

    Article • PROTEOMICS, October 2009, Wiley

    Professor Albert Pares

  82. Incidence, Risk Factors, and Survival of Hepatocellular Carcinoma in Primary Biliary Cirrhosis

    Article • Hepatology, October 2009, Wolters Kluwer Health

    Professor Albert Pares

  83. Utilidad del ácido ursodeoxicólico en la colangitis esclerosante primaria

    Article • Gastroenterología y Hepatología Continuada, August 2009, Elsevier

    Professor Albert Pares

  84. New ELISA for Detecting Primary Biliary Cirrhosis-Specific Antimitochondrial Antibodies

    Article • Clinical Chemistry, March 2009, AACC

    Professor Albert Pares, Professor DIMITRIOS P BOGDANOS

  85. High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue

    Article • Journal of Bone and Mineral Metabolism, February 2009, Springer Science + Business Media

    Professor Albert Pares

  86. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure

    Article • Critical Care, January 2009, Springer Science + Business Media

    Professor Albert Pares

  87. Excellent long-term survival in patients with primary biliary cirrhosis treated with ursodeoxycholic acid

    Article • January 2009, Springer Science + Business Media

    Professor Albert Pares

  88. Historia natural de la cirrosis biliar primaria

    Article • Gastroenterología y Hepatología, October 2008, Elsevier

    Professor Albert Pares

  89. Simplified criteria for the diagnosis of autoimmune hepatitis†

    Article • Hepatology, July 2008, Wolters Kluwer Health

    Professor Albert Pares

  90. Osteoporosis in Primary Biliary Cirrhosis: Pathogenesis and Treatment

    Article • Clinics in Liver Disease, May 2008, Elsevier

    Professor Albert Pares

  91. 874 INCIDENCE AND RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PRIMARY BILIARY CIRRHOSIS

    Article • Journal of Hepatology, January 2008, Elsevier

    Professor Albert Pares

  92. 123 PRESENTATION AND NATURAL HISTORY OF PRIMARY BILIARY CIRRHOSIS IN SPAIN: EXPERIENCE OVER 35 YEARS

    Article • Journal of Hepatology, January 2008, Elsevier

    Professor Albert Pares

  93. Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis

    Article • Hepatology, June 2007, Wolters Kluwer Health

    Professor Albert Pares, Professor DIMITRIOS P BOGDANOS

  94. Serum paraoxonase-1 in chronic alcoholics: Relationship with liver disease

    Article • Clinical Biochemistry, June 2007, Elsevier

    Professor Albert Pares

  95. Treatment of bone disorders in liver disease

    Article • Journal of Hepatology, September 2006, Elsevier

    Professor Albert Pares

  96. Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid

    Article • Gastroenterology, March 2006, Elsevier

    Professor Albert Pares

  97. Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature

    Article • Journal of Viral Hepatitis, November 2005, Wiley

    Professor Albert Pares

  98. Prevalence and Mechanisms of Hyperhomocysteinemia in Chronic Alcoholics

    Article • Alcoholism Clinical and Experimental Research, June 2005, Wiley

    Professor Albert Pares

  99. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis

    Article • Journal of Hepatology, April 2005, Elsevier

    Professor Albert Pares

  100. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis

    Article • Gut, April 2005, BMJ

    Professor Albert Pares, Professor DIMITRIOS P BOGDANOS

  101. Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis

    Article • European Journal of Gastroenterology & Hepatology, March 2005, Wolters Kluwer Health

    Professor Albert Pares

  102. Serum Immunological Profile in Patients with Chronic Autoimmune Cholestasis

    Article • The American Journal of Gastroenterology, November 2004, Wolters Kluwer Health

    Professor Albert Pares

  103. Colangitis esclerosante primaria

    Article • Gastroenterología y Hepatología, November 2004, Elsevier

    Professor Albert Pares

  104. Tratamiento de las complicaciones óseas

    Article • Gastroenterología y Hepatología, October 2004, Elsevier

    Professor Albert Pares

  105. Extracorporeal Albumin Dialysis: A Procedure for Prolonged Relief of Intractable Pruritus in Patients with Primary Biliary Cirrhosis

    Article • The American Journal of Gastroenterology, June 2004, Wolters Kluwer Health

    Professor Albert Pares

  106. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis

    Article • Journal of Autoimmunity, June 2004, Elsevier

    Professor Albert Pares, Professor DIMITRIOS P BOGDANOS

  107. Primary Biliary Cirrhosis Specific Antinuclear Antibodies in Patients from Spain

    Article • The American Journal of Gastroenterology, April 2004, Wolters Kluwer Health

    Professor Albert Pares, Professor DIMITRIOS P BOGDANOS

  108. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis

    Article • Journal of Hepatology, January 2004, Elsevier

    Professor Albert Pares

  109. Colangitis esclerosante primaria

    Article • Gastroenterología y Hepatología, January 2004, Elsevier

    Professor Albert Pares

  110. Natural history of primary biliary cirrhosis

    Article • Clinics in Liver Disease, November 2003, Elsevier

    Professor Albert Pares

  111. Alendronate Is More Effective Than Etidronate for Increasing Bone Mass in Osteopenic Patients With Primary Biliary Cirrhosis

    Article • The American Journal of Gastroenterology, October 2003, Wolters Kluwer Health

    Professor Albert Pares

  112. Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis

    Article • The American Journal of Gastroenterology, October 2003, Nature

    Professor Albert Pares

  113. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis

    Article • Journal of Hepatology, July 2003, Elsevier

    Professor Albert Pares

  114. Expected developments in hepatology

    Article • Best Practice & Research Clinical Gastroenterology, December 2002, Elsevier

    Professor Albert Pares

  115. Cerebral consequences of alcoholic liver disease

    Article • May 2002, Taylor & Francis

    Professor Albert Pares

  116. Hyperhomocysteinemia in chronic alcoholism. Relationship to liver damage

    Article • Journal of Hepatology, April 2002, Elsevier

    Professor Albert Pares

  117. The molecular adsorbent recirculating system (MARS) improves systemic hemodynamics and hepatic encephalopathy in patients with severe alcoholic hepatitis

    Article • Journal of Hepatology, April 2002, Elsevier

    Professor Albert Pares

  118. Molecular adsorbent recirculating system: a new procedure for relieving intractable pruritus in patients with primary biliary cirrhosis

    Article • Journal of Hepatology, April 2002, Elsevier

    Professor Albert Pares

  119. Duration and severity of the disease but not menopausal status are the main risk factors for osteoporosis in primary biliary cirrhosis

    Article • Journal of Hepatology, April 2002, Elsevier

    Professor Albert Pares

  120. Genetic polymorphisms of alcohol metabolizing enzymes do not influence the development of alcoholic liver disease

    Article • Journal of Hepatology, April 2002, Elsevier

    Professor Albert Pares

  121. Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis

    Article • Hepatology, March 2002, Wiley

    Professor Albert Pares

  122. Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation

    Article • Scandinavian Journal of Gastroenterology, January 2002, Taylor & Francis

    Professor Albert Pares

  123. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis

    Article • Gut, August 2001, BMJ

    Professor Albert Pares

  124. Hepatocellular Carcinoma in Primary Biliary Cirrhosis: Similar Incidence To That in Hepatitis C Virus–Related Cirrhosis

    Article • The American Journal of Gastroenterology, April 2001, Wolters Kluwer Health

    Professor Albert Pares

  125. Long-term ursodeoxycholic acid treatment delays progression of mild primary biliary cirrhosis

    Article • Journal of Hepatology, April 2001, Elsevier

    Professor Albert Pares

  126. Factors influencing histological progression of early primary biliary cirrhosis. Effect of ursodeoxycholic acid

    Article • Journal of Hepatology, April 2001, Elsevier

    Professor Albert Pares

  127. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus–related cirrhosis

    Article • The American Journal of Gastroenterology, April 2001, Nature

    Professor Albert Pares

  128. Collagen type Iα1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis

    Article • Hepatology, March 2001, Wiley

    Professor Albert Pares

  129. S-Adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats

    Article • Clinical Science, October 2000, Portland Press Ltd.

    Professor Albert Pares

  130. Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis

    Article • Journal of Hepatology, October 2000, Wiley

    Professor Albert Pares

  131. Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis

    Article • Journal of Hepatology, October 2000, Elsevier

    Professor Albert Pares

  132. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial

    Article • Hepatology, July 2000, Wolters Kluwer Health

    Professor Albert Pares

  133. Enhanced DNA Binding and Activation of Transcription Factors NF-kappa B and AP-1 by Acetaldehyde in HEPG2 Cells

    Article • Journal of Biological Chemistry, May 2000, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Albert Pares

  134. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial

    Article • Journal of Hepatology, April 2000, Elsevier

    Professor Albert Pares

  135. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development

    Article • Journal of Hepatology, March 2000, Elsevier

    Professor Albert Pares

  136. Prevalencia y factores asociados a la presencia de esteatosis hepática en varones adultos aparentemente sanos

    Article • Medicina Clínica, January 2000, Elsevier

    Professor Albert Pares

  137. S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial

    Article • Journal of Hepatology, June 1999, Elsevier

    Professor Albert Pares

  138. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations

    Article • Tissue Antigens, May 1999, Wiley

    Professor Albert Pares

  139. High Bilirubin Levels Interfere with Serum Tartrate-Resistant Acid Phosphatase Determination: Relevance as a Marker of Bone Resorption in Jaundiced Patients

    Article • Calcified Tissue International, April 1999, Springer Science + Business Media

    Professor Albert Pares

  140. Effects of silymarin in alcoholic patients with cirrhosis of the liver

    Article • European Journal of Gastroenterology & Hepatology, July 1998, Wolters Kluwer Health

    Professor Albert Pares

  141. Collagen‐Related Markers of Bone Turnover Reflect the Severity of Liver Fibrosis in Patients with Primary Biliary Cirrhosis

    Article • Journal of Bone and Mineral Research, April 1998, Oxford University Press (OUP)

    Professor Albert Pares

  142. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial

    Article • Journal of Hepatology, April 1998, Elsevier

    Professor Albert Pares

  143. Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial

    Article • Journal of Hepatology, January 1998, Elsevier

    Professor Albert Pares, Prof. Luis Rodrigo

  144. Management of primary biliary cirrhosis: osteoporosis

    Article • January 1998, Springer Science + Business Media

    Professor Albert Pares

  145. Zinc Administration Improves Gastric Alcohol Dehydrogenase Activity and First‐Pass Metabolism of Ethanol in Alcohol‐Fed Rats

    Article • Alcoholism Clinical and Experimental Research, December 1997, Wiley

    Professor Albert Pares

  146. Carbohydrate‐Deficient Transferrin as a Marker of Alcohol Consumption in Male Patients with Liver Disease

    Article • Alcoholism Clinical and Experimental Research, August 1997, Wiley

    Professor Albert Pares

  147. Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: Preliminary results after 2 years

    Article • Gastroenterology, July 1997, Elsevier

    Professor Albert Pares

  148. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis

    Article • Hepatology, December 1996, Wiley

    Professor Albert Pares

  149. Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis

    Article • Journal of Hepatology, August 1996, Elsevier

    Professor Albert Pares, Dr María Ángeles Pajares

  150. Effects of ethanol feeding and malnutrition on collagen synthesizing and degrading enzymes in rat pancreas

    Article • Alcohol, May 1996, Elsevier

    Professor Albert Pares

  151. Serum Amino-Terminal Propeptide of Type III Procollagen Levels in Chronic Pancreatitis

    Article • Pancreas, March 1996, Wolters Kluwer Health

    Professor Albert Pares

  152. Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?

    Article • Journal of Hepatology, January 1996, Elsevier

    Professor Albert Pares

  153. Vertebral fractures and osteopenia in chronic alcoholic patients

    Article • Calcified Tissue International, August 1995, Springer Science + Business Media

    Professor Albert Pares

  154. Bone mass improves in alcoholics after 2 years of abstinence

    Article • Journal of Bone and Mineral Research, October 1994, Oxford University Press (OUP)

    Professor Albert Pares

  155. Acetaldehyde activates the promoter of the mouse α2(I) collagen gene

    Article • Hepatology, February 1994, Wolters Kluwer Health

    Professor Albert Pares

  156. Acetaldehyde activates the promoter of the mouse $alpha;2(I) collagen gene*1

    Article • Hepatology, February 1994, Elsevier

    Professor Albert Pares

  157. Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration

    Article • Journal of Hepatology, January 1994, Elsevier

    Professor Albert Pares

  158. Epidemiology of primary sclerosing cholangitis in Spain

    Article • Journal of Hepatology, January 1994, Elsevier

    Professor Albert Pares

  159. Cyclosporin A increases the biochemical markers of bone remodeling in primary biliary cirrhosis

    Article • Journal of Hepatology, January 1994, Elsevier

    Professor Albert Pares

  160. Disulfiram-induced hepatitis. Report of four cases and review of the literature

    Article • Journal of Hepatology, January 1994, Elsevier

    Professor Albert Pares

  161. Determinants of Ethanol and Acetaldehyde Metabolism in Chronic Alcoholics

    Article • Alcoholism Clinical and Experimental Research, February 1993, Wiley

    Professor Albert Pares

  162. Drinking in the Injury Event: A Comparison of Emergency Room Populations in the United States, Mexico, and Spain

    Article • International Journal of the Addictions, January 1993, Taylor & Francis

    Professor Albert Pares

  163. S –Adenosylmethionine Treatment Prevents Carbon Tetrachloride—Induced S –Adenosylmethionine Synthetase Inactivation and Attenuates Liver Injury

    Article • Hepatology, October 1992, Wolters Kluwer Health

    Professor Albert Pares, Dr María Ángeles Pajares

  164. Influence of Dietary Zinc on Hepatic Collagen and Prolyl Hydroxylase Activity in Alcoholic Rats

    Article • Hepatology, September 1992, Wolters Kluwer Health

    Professor Albert Pares

  165. Sodium fluoride prevents bone loss in primary biliary cirrhosis

    Article • Journal of Hepatology, July 1992, Elsevier

    Professor Albert Pares

  166. Primary Biliary Cirrhosis and Sclerosing Cholangitis

    Article • January 1992, Springer Science + Business Media

    Professor Albert Pares

  167. Are hepatitis C virus antibodies involved in chronic liver diseases other than non-A, non-B hepatitis?

    Article • Hepatology, December 1991, Wolters Kluwer Health

    Professor Albert Pares

  168. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: A randomized controlled trial

    Article • Hepatology, December 1991, Wolters Kluwer Health

    Professor Albert Pares

  169. Reply

    Article • Hepatology, December 1991, Elsevier

    Professor Albert Pares

  170. Anemia in primary biliary cirrhosis (PBC). A new prognostic feature

    Article • Journal of Hepatology, January 1991, Elsevier

    Professor Albert Pares

  171. Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury

    Article • Hepatology, December 1990, Wolters Kluwer Health

    Professor Albert Pares

  172. Liver diseases associated with autoantibodies directed to nuclear envelope components

    Article • Hepatology, June 1989, Wolters Kluwer Health

    Professor Albert Pares

  173. Alcoholic foamy degeneration in Spain. Prevalence and clinico‐pathological features

    Article • Liver International, April 1989, Wiley

    Professor Albert Pares

  174. COMPARISON OF RIFAMPICIN WITH PHENOBARBITONE FOR TREATMENT OF PRURITUS IN BILIARY CIRRHOSIS

    Article • The Lancet, March 1989, Elsevier

    Professor Albert Pares

  175. Comparative study of aminoglycoside nephrotoxicity in normal rats and rats with experimental cirrhosis

    Article • Hepatology, July 1988, Wolters Kluwer Health

    Professor Albert Pares

  176. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis

    Article • Hepatology, July 1988, Wolters Kluwer Health

    Professor Albert Pares

  177. Esophageal dysfunction in primary biliary cirrhosis

    Article • Journal of Hepatology, January 1988, Elsevier

    Professor Albert Pares

  178. Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B

    Article • Journal of Hepatology, January 1988, Elsevier

    Professor Albert Pares

  179. Cyanamide hepatotoxicity. Incidence and clinicopathological features

    Article • Liver International, August 1987, Wiley

    Professor Albert Pares

  180. Portal hypertension in primary biliary cirrhosis

    Article • Journal of Hepatology, January 1987, Elsevier

    Professor Albert Pares

  181. Histological course of alcoholic hepatitis

    Article • Journal of Hepatology, January 1986, Elsevier

    Professor Albert Pares

  182. Measurement of Fibrosis in Needle Liver Biopsies: Evaluation of A Colorimetric Method

    Article • Hepatology, September 1985, Wolters Kluwer Health

    Professor Albert Pares

  183. Lymphocytotoxic antibodies in primary biliary cirrhosis

    Article • Digestive Diseases and Sciences, September 1985, Springer Science + Business Media

    Professor Albert Pares

  184. Acute Thallium Poisoning: An Evaluation of Different Forms of Treatment

    Article • Journal of Toxicology Clinical Toxicology, January 1982, Taylor & Francis

    Professor Albert Pares

  185. Nonoliguric acute renal failure in an intensive care unit

    Article • Intensive Care Medicine, December 1980, Springer Science + Business Media

    Professor Albert Pares

  186. Primary Biliary Cirrhosis Associated with HLA—DRw3

    Article • Tissue Antigens, November 1979, Wiley

    Professor Albert Pares